Resource Center

More information?
More information?
25 RESULTS FOUND
Committed Signatures
January 20, 2017
Administrative
Fact Sheet: Unleashing the Power of Diagnostic Tests in the Fight Against Antibiotic Resistance
January 12, 2017
Whitepaper
AdvaMedDx Comments on Draft Guidance for Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices
November 29, 2016
Comments
AdvaMedDx Comment Letter CMS-3295-P Changes to Promote Innovation
September 9, 2016
Letter
AdvaMedDx Statement at Public Meeting of the Presidential Advisory Council for CARB
September 9, 2016
Testimony
Overview of Diagnostic Test Technologies
August 22, 2016
Primer
Value of Molecular Diagnostics
August 22, 2016
Primer
Risk-Based Approach to Regulation of Diagnostics
August 15, 2016
Guidance
Comments to FDA on LDT Framework
August 3, 2016
Comments
Introduction to Molecular Diagnostics, The Essentials of Diagnostics Series (PDF)
August 3, 2016
Primer
Payment Reform & Deficit Reduction Infographic
August 1, 2016
Infographic
AdvaMedDx Letter to HHS Secretary Burwell on Common Rule NPRM
June 14, 2016
Letter
A Public Health Perspective on Antimicrobial Resistance Diagnostics: CDC-AdvaMedDx Meeting Report
March 1, 2016
Summary
The Importance of Diagnostic Tests in Fighting Infectious Diseases
February 2, 2016
Fact Sheet
The Value of Diagnostics in Detecting Cervical Cancer
January 1, 2016
Study
The Value of Molecular Diagnostics: Advancing Cancer Treatment and Care
January 1, 2016
Study
Executive Summary: The Value of Molecular Diagnostics: Advancing Cancer Treatment and Care
November 30, 2015
Primer
AdvaMedDx Comments to CMS Regarding Clinical Diagnostic Laboratory Tests Payment System Proposed Rule
November 24, 2015
Comments
AdvaMedDx Statement at CMS Clinical Laboratory Public Meeting July 2015
July 16, 2015
Comments
Comments to FDA on Next Generation Sequencing
March 20, 2015
Comments
Comments to FDA on Staff-Flow Cytometric Devices 
January 12, 2015
Comments
AdvaMedDx Comments to 21st Century Cures Request for Feedback
January 5, 2015
Comments
Comments to FDA on Staff-Flow Cytometric Devices 
January 5, 2015
Comments
Stakeholder Statements on the Regulation of Laboratory Developed Tests
September 19, 2014
Comments
AdvaMedDx Testimony to House Energy & Commerce Committee on Regulation of Laboratory Developed Tests 
September 9, 2014
Testimony

Pages